PNC Financial Services Group
PBE icon

PNC Financial Services Group’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

PNC Financial Services Group’s Portfolio PBE Stock Details PBE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.4K Sell
327
-100
-23% -$8.24K ﹤0.01% 3604
2026
Q1 		$33.8K Sell
427
-88
-17% -$7.11K ﹤0.01% 3440
2025
Q4 		$42.3K Sell
515
-59
-10% -$4.57K ﹤0.01% 3303
2025
Q3 		$40.1K Buy
574
+245
+74% +$16.6K ﹤0.01% 3329
2025
Q2 		$21.1K Sell
329
-68
-17% -$4.21K ﹤0.01% 3548
2025
Q1 		$25.2K Sell
397
-58
-13% -$3.9K ﹤0.01% 3438
2024
Q4 		$30.3K Hold
455
– – ﹤0.01% 3349
2024
Q3 		$31.8K Sell
455
-116
-20% -$8.03K ﹤0.01% 3297
2024
Q2 		$37K Buy
571
+78
+16% +$4.94K ﹤0.01% 3172
2024
Q1 		$31.9K Buy
493
+193
+64% +$12.6K ﹤0.01% 3212
2023
Q4 		$19.8K Buy
300
+60
+25% +$3.49K ﹤0.01% 3439
2023
Q3 		$13.7K Hold
240
– – ﹤0.01% 3624
2023
Q2 		$14.7K Buy
240
+40
+20% +$2.5K ﹤0.01% 3695
2023
Q1 		$12.6K Hold
200
– – ﹤0.01% 3706
2022
Q4 		$12.7K Sell
200
-34
-15% -$2.16K ﹤0.01% 3675
2022
Q3 		$14K Hold
234
– – ﹤0.01% 3612
2022
Q2 		$14K Hold
234
– – ﹤0.01% 3659
2022
Q1 		$15K Hold
234
– – ﹤0.01% 3706
2021
Q4 		$17K Hold
234
– – ﹤0.01% 3614
2021
Q3 		$18K Hold
234
– – ﹤0.01% 3557
2021
Q2 		$18K Hold
234
– – ﹤0.01% 3521
2021
Q1 		$17K Hold
234
– – ﹤0.01% 3473
2020
Q4 		$16K Buy
234
+34
+17% +$2.15K ﹤0.01% 3428
2020
Q3 		$11K Hold
200
– – ﹤0.01% 3471
2020
Q2 		$12K Sell
200
-800
-80% -$43.6K ﹤0.01% 3411
2020
Q1 		$46K Sell
1,000
-125
-11% -$6.52K ﹤0.01% 2686
2019
Q4 		$63K Hold
1,125
– – ﹤0.01% 2760
2019
Q3 		$53K Hold
1,125
– – ﹤0.01% 2869
2019
Q2 		$61K Buy
1,125
+130
+13% +$6.74K ﹤0.01% 2835
2019
Q1 		$55K Sell
995
-75
-7% -$3.96K ﹤0.01% 2890
2018
Q4 		$50K Hold
1,070
– – ﹤0.01% 2865
2018
Q3 		$63K Sell
1,070
-930
-47% -$54.3K ﹤0.01% 2863
2018
Q2 		$109K Hold
2,000
– – ﹤0.01% 2536
2018
Q1 		$98K Buy
2,000
+1,782
+817% +$90.9K ﹤0.01% 2570
2017
Q4 		$10K Hold
218
– – ﹤0.01% 3697
2017
Q3 		$11K Hold
218
– – ﹤0.01% 3650
2017
Q2 		$10K Hold
218
– – ﹤0.01% 3581
2017
Q1 		$9K Hold
218
– – ﹤0.01% 3573
2016
Q4 		$8K Sell
218
-140
-39% -$5.65K ﹤0.01% 3552
2016
Q3 		$15K Sell
358
-450
-56% -$18.5K ﹤0.01% 3354
2016
Q2 		$30K Hold
808
– – ﹤0.01% 3077
2016
Q1 		$31K Sell
808
-140
-15% -$5.44K ﹤0.01% 3050
2015
Q4 		$48K Hold
948
– – ﹤0.01% 2856
2015
Q3 		$43K Buy
948
+50
+6% +$2.79K ﹤0.01% 2957
2015
Q2 		$52K Hold
898
– – ﹤0.01% 2990
2015
Q1 		$50K Buy
898
+848
+1,696% +$45.8K ﹤0.01% 3041
2014
Q4 		$3K Buy
+50
New +$2.45K ﹤0.01% 3692
2014
Q2 		– Sell
-1,006
Closed -$42K – 3880
2014
Q1 		$42K Hold
1,006
– – ﹤0.01% 2571
2013
Q4 		$38K Buy
+1,006
New +$36.1K ﹤0.01% 2597

Other funds holding PBE

LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.75B AUM 28.61% 1-Year Est. Return
YIA
YHB Investment Advisors West Hartford, Connecticut $1.56B AUM 27.39% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
IFWM
Institute for Wealth Management Denver, Colorado $1.13B AUM 39.73% 1-Year Est. Return
PIM
Penobscot Investment Management Boston, Massachusetts $1.46B AUM 32.32% 1-Year Est. Return
MWM
Massachusetts Wealth Management North Andover, Massachusetts $262M AUM 48.07% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
AFM
Abbot Financial Management Andover, Massachusetts $293M AUM 36.12% 1-Year Est. Return
BEI
Benjamin Edwards Inc Clayton, Missouri $11B AUM 18.22% 1-Year Est. Return

PNC Financial Services Group's PBE Position: Q2 2026 in Review

PNC Financial Services Group reduced its Invesco Biotechnology & Genome ETF (PBE) stake by 23% in Q2 2026, selling an estimated $8.24K and leaving 327 shares worth $29.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3604.

PNC Financial Services Group first reported a position in PBE in Q4 2013 and has held it in 49 quarters since. The position peaked at $109K in Q2 2018. 53 funds tracked by Wall St. Rank hold PBE as of Q2 2026.

  • PNC Financial Services Group held 327 shares of Invesco Biotechnology & Genome ETF worth $29.4K as of Q2 2026.
  • PNC Financial Services Group sold 100 Invesco Biotechnology & Genome ETF shares in Q2 2026, an estimated $8.24K.
  • Invesco Biotechnology & Genome ETF made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #3604 holding.
  • PNC Financial Services Group first reported a position in Invesco Biotechnology & Genome ETF in Q4 2013 and has held it in 49 quarters since.
  • PNC Financial Services Group's Invesco Biotechnology & Genome ETF position peaked at $109K in Q2 2018.
  • 53 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.